FDA Approves Trulance for Chronic Idiopathic Constipation

Share this content:
FDA Approves Trulance for Chronic Idiopathic Constipation
FDA Approves Trulance for Chronic Idiopathic Constipation

FRIDAY, Jan. 20, 2017 (HealthDay News) -- Trulance (plecanatide) has been approved by the U.S. Food and Drug Administration to treat persistent idiopathic constipation in adults.

Once-daily Trulance is designed to stimulate the gastrointestinal tract to secrete fluid and "support regular bowel function," the FDA said in a news release.

The oral drug was evaluated in two 12-week clinical studies involving a total of 1,775 adults with chronic constipation. Compared to patients taking placebo, those taking Trulance were more likely to experience improvement in the frequency of complete spontaneous bowel movements, as well as improvements in stool frequency and consistency and straining. Diarrhea was the most common side effect. If diarrhea becomes severe, users should stop taking Trulance and contact a doctor, the FDA advised.

"No one medication works for all patients suffering from chronic gastrointestinal disorders," Julie Beitz, M.D., director of the Office of Drug Evaluation III in the FDA's Center for Drug Evaluation and Research, said in a statement. "With the availability of new therapies, patients and their doctors can select the most appropriate treatment for their condition."

Trulance is produced by New York City-based Synergy Pharmaceuticals.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA Warns of Possible Heart Risks Linked to Clarithromycin

FDA Warns of Possible Heart Risks Linked to ...

Agency advising doctors to consider prescribing other antibiotics to patients with coronary heart disease

Artificial Intelligence May Help Prevent Physician Burnout

Artificial Intelligence May Help Prevent Physician Burnout

Many potential uses for AI, including improving searches and documentation, selecting treatment

Benzodiazepine Use Declining in Older Adults

Benzodiazepine Use Declining in Older Adults

Findings based on assessment of incidence, prevalence of use in three countries from 2010-2016

is free, fast, and customized just for you!

Already a member?

Sign In Now »